Nephrogenic systemic fibrosis: A histopathological study of eight cases of a recently described entity

Histopathology

Volumn 52, Issue 4, 2008, Pages 531-534

  Digby, S ^a   MacDuff, E ^a   Blessing, K ^a   Holmes, S ^b  

^a WESTERN INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIBODY; CHLORDANE; GADOLINIUM; PROCOLLAGEN;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; EOSINOPHILIC FASCIITIS; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; LETTER; MALE; MULTINUCLEAR CELL; NEPHROGENIC FIBROSING DERMOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPULE; PATHOGENESIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SCLEROMYXEDEMA; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD34; BIOLOGICAL MARKERS; COLLAGEN; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; FASCIITIS; FATAL OUTCOME; FEMALE; FIBROSIS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; SCLERODERMA, SYSTEMIC; SCLEROMYXEDEMA; SKIN; SKIN DISEASES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 40149086681     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.02947.x     Document Type: Letter

References (8)

1. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE. Nephrogenic fibrosing dermopathy. Am. J. Dermatopathol. 2001 23 383 393.
2. Cowper SE. Nephrogenic fibrosing dermopathy; the first six years. Curr. Opin. Rheumatol. 2003 15 785 790.
3. Cowper SE. Nephrogenic fibrosing dermopathy [NFD/NSF Website], 2001-2007. Available at: http://www.icnfdr.org accessed 1 June 2007.
4. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol. Dial. Transplant. 2006 21 1104 1108.
5. Cowper SE, Bucala R. Nephrogenic fibrosing dermopathy: suspect identified, motive unclear. Am. J. Dermatopathol. 2003 25 358.
6. Kucher C, Xu X, Pasha T, Elenitsas R. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J. Cutan. Pathol. 2005 32 484 490.
7. Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr. Rheumatol. Rep. 2006 8 145 150.
8. Jimenez SA, Artlett CM, Sandorfi N et al. Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum. 2004 50 2660 2666.